List of insiders holdings for Aimmune Therapeutics Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| Societe des Produits Nestle S.A. 10% Owner | 2020-10-15 19:18:28 | 13,252,747 23,408,817 | 36,661,564 | Form 4 |
| Longitude Capital Partners II LLC Tammenoms Bakker Juliet Longitude Venture Partners II L.P. 10% Owner | 2020-02-12 16:24:37 | 6,215,278 0 | 6,215,278 | Form 13G |
| Tammenoms Bakker Juliet 10% Owner | 2018-02-26 16:25:25 | 16,651 6,013,134 | 6,029,785 | Form 4 |
| DILLY STEPHEN GEORGE President and CEO | 2018-06-13 16:06:33 | 611,250 131,700 | 742,950 | Form 4 |
| Raff Howard V. Chief Operating Officer | 2015-08-05 18:41:49 | 98,775 428,575 | 527,350 | Form 3 |
| Elfont Robert Myles Chief Medical Officer | 2016-02-26 19:35:27 | 379,002 0 | 379,002 | Form 4 |
| DeSouza Warren L. Chief Financial Officer | 2017-04-05 16:05:35 | 324,475 0 | 324,475 | Form 4 |
| Knapp Jeffrey H Chief Operating Officer | 2018-03-06 20:42:30 | 68,401 0 | 68,401 | Form 4 |
| Barrowcliffe Susan E. General Manager, Europe | 2018-11-21 16:05:54 | 62,775 0 | 62,775 | Form 4 |
| Rozenman Mary M. See Remarks | 2020-02-14 17:23:52 | 13,878 0 | 13,878 | Form 5 |
| Behar Gregory Director | 2020-10-14 16:15:28 | 10,192 0 | 10,192 | Form 4 |
| Nestle Health Science US Holdings Inc. Societe des Produits Nestle S.A. NESTLE SA NIMCO US Inc. Nestle US Holdco Inc. 10% Owner | 2020-10-13 10:48:59 | 100 0 | 100 | Form 13D |
| Societe des Produits Nestle S.A. NESTLE SA 10% Owner | 2020-10-13 10:48:59 | 100 0 | 100 | Form 13D |
| Foresite Capital Management II LLC Foresite Capital Fund II L.P. Foresite Capital Management III LLC Foresite Capital Fund III L.P. Tananbaum James B. 10% Owner | 2020-02-13 21:20:20 | 0 0 | 0 | Form 13G |
| Oxtoby Andrew Chief Commercial Officer | 2020-10-14 16:15:36 | 0 0 | 0 | Form 4 |
| Sheehy Douglas T. See Remarks | 2020-10-14 16:15:34 | 0 0 | 0 | Form 4 |
| Dallas Jayson Donald Alexander President and CEO | 2020-10-14 16:15:31 | 0 0 | 0 | Form 4 |
| MCDADE MARK Director | 2020-10-14 16:15:30 | 0 0 | 0 | Form 4 |
| HAUMANN BRETT K Director | 2020-10-14 16:15:24 | 0 0 | 0 | Form 4 |
| Seltzer Stacey Denenberg Director | 2020-10-14 16:15:23 | 0 0 | 0 | Form 4 |
| BJERKHOLT ERIC Chief Financial Officer | 2020-10-14 16:15:18 | 0 0 | 0 | Form 4 |
| Iwicki Mark T Director | 2020-10-14 16:15:14 | 0 0 | 0 | Form 4 |
| ENRIGHT PATRICK G Director | 2020-10-14 16:15:14 | 0 0 | 0 | Form 4 |
| FALBERG KATHRYN E Director | 2020-10-14 16:15:10 | 0 0 | 0 | Form 4 |
| ADELMAN DANIEL C MD Chief Medical Officer | 2020-10-14 16:15:11 | 0 0 | 0 | Form 4 |